Endophthalmitis: Antibacterial activity of precipitates of vancomycin and ceftazidime

被引：6
|
作者：
Chen, Kuan-Jen [1 ]
Chen, Tun-Lu [1 ]
Lai, Chi-Chun [1 ]
Sun, Ming-Hui [1 ]
机构：
[1] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Ophthalmol, Tao Yuan, Taiwan
来源：
JOURNAL OF CLINICAL MICROBIOLOGY | 2008年 / 46卷 / 06期
关键词：
D O I：
10.1128/JCM.00728-08
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：2149 / 2149
页数：1
相关论文
共 50 条
  • [1] Physicochemical properties and antibacterial activity of the precipitate of vancomycin and ceftazidime - Implications in the management of Endophthalmitis
    Raju, Biju
    Bali, Tinku
    Thiagarajan, Geetha
    Rao, Venkateshwara
    Das, Taraprasad
    Sharma, Savitri
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2008, 28 (02): : 320 - 325
  • [2] Susceptibility of bacterial endophthalmitis isolates to vancomycin, ceftazidime, and amikacin
    Chen, Kuan-Jen
    Sun, Ming-Hui
    Hou, Chiun-Ho
    Chen, Hung-Chi
    Chen, Yen-Po
    Wang, Nan-Kai
    Liu, Laura
    Wu, Wei-Chi
    Chou, Hung-Da
    Kang, Eugene Yu-Chuan
    Lai, Chi-Chun
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [3] Susceptibility of bacterial endophthalmitis isolates to vancomycin, ceftazidime, and amikacin
    Kuan-Jen Chen
    Ming-Hui Sun
    Chiun-Ho Hou
    Hung-Chi Chen
    Yen-Po Chen
    Nan-Kai Wang
    Laura Liu
    Wei-Chi Wu
    Hung-Da Chou
    Eugene Yu-Chuan Kang
    Chi-Chun Lai
    Scientific Reports, 11
  • [4] Intravitreal Moxifloxacin for the Treatment of Vancomycin/Ceftazidime-Resistant Endophthalmitis
    Zavala Ayala, A.
    Velez-Montoya, R.
    Quiroz-Mercado, H.
    Vanzinni-Zago, V.
    Ortiz-Gonzalez, A.
    Morales-Canton, V.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [5] Intravitreal levels of ceftazidime and vancomycin measured in human patients with endophthalmitis.
    Allen, PJ
    Weberruss, M
    Paull, P
    Maclean, H
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S354 - S354
  • [6] Intravitreal triple therapy with vancomycin, ceftazidime and moxifloxacin for post-cataract endophthalmitis
    Taubenslag, Kenneth
    Cherney, Edward
    Patel, Shriji
    Law, Janice
    Daniels, Anthony
    Kim, Stephen
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [7] Are fluoroquinolones synergistic in combination with vancomycin, amikacin, and ceftazidime? Possible implication in treatment of bacterial endophthalmitis
    Das, T
    Lall, A
    Duggirala, A
    Sharma, S
    Rao, VD
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [8] Susceptibility of bacterial isolates to vancomycin and ceftazidime from patients with endophthalmitis: Is there a need to change the empirical therapy in suspected bacterial endophthalmitis?
    Reddy, Ashok Kumar
    Reddy, Raja Rami
    Paruvelli, Muralidhar Rao
    Ambatipudi, Srinivas
    Rani, Alka
    Lodhi, Sikander A. K.
    Reddy, Juturi Maruthi Lokabhi
    Reddy, K. Ramakanth
    Pandey, Niraj
    Videkar, Rituraj
    Sinha, Manish Kumar
    Majji, Ajit Babu
    Deb-Jorder, Nilanjana
    Sahu, Atul Kumar
    Myneni, Jyostna
    Abraham, Anina
    INTERNATIONAL OPHTHALMOLOGY, 2015, 35 (01) : 37 - 42
  • [9] Susceptibility of bacterial isolates to vancomycin and ceftazidime from patients with endophthalmitis: Is there a need to change the empirical therapy in suspected bacterial endophthalmitis?
    Ashok Kumar Reddy
    Raja Rami Reddy
    Muralidhar Rao Paruvelli
    Srinivas Ambatipudi
    Alka Rani
    Sikander A. K. Lodhi
    Juturi Maruthi Lokabhi Reddy
    K. Ramakanth Reddy
    Niraj Pandey
    Rituraj Videkar
    Manish Kumar Sinha
    Ajit Babu Majji
    Nilanjana Deb-Jorder
    Atul Kumar Sahu
    Jyostna Myneni
    Anina Abraham
    International Ophthalmology, 2015, 35 : 37 - 42
  • [10] Intravitreal triple therapy with vancomycin, ceftazidime, and moxifloxacin for bacterial endophthalmitis: A Twelve-year experience
    Kenneth J. Taubenslag
    Edward F. Cherney
    Shriji N. Patel
    Janice C. Law
    Anthony B. Daniels
    Stephen J. Kim
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2023, 261 : 2813 - 2819
12345